Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Stem Cell Res Ther. 2021 Sep 6;12(1):493. doi: 10.1186/s13287-021-02566-5.
Stem Cell Res Ther. 2021.
PMID: 34488861
Free PMC article.
No abstract available.
CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P.
Xue BZ, et al. Among authors: abdelmaksou a.
Stem Cell Res Ther. 2021 Jul 13;12(1):394. doi: 10.1186/s13287-021-02458-8.
Stem Cell Res Ther. 2021.
PMID: 34256854
Free PMC article.
Item in Clipboard
CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.
Zhang Q, Yi DY, Xue BZ, Wen WW, Lu YP, Abdelmaksou A, Sun MX, Yuan DT, Zhao HY, Xiong NX, Xiang W, Fu P.
Zhang Q, et al. Among authors: abdelmaksou a.
Cell Death Dis. 2018 Oct 27;9(11):1101. doi: 10.1038/s41419-018-1140-6.
Cell Death Dis. 2018.
PMID: 30368520
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.